Godrej Industries Limited reported robust financial growth for the fiscal year ending March 31, 2026. The company achieved a consolidated total income of ₹25,981 crore, marking a 19% year-on-year increase. Consolidated net profit rose significantly to ₹1,241 crore, a 26% growth compared to the previous year. This performance was driven by strong segment results, particularly in Estate and Property Development, which saw significant revenue and profitability contributions.
Consolidated Financial Performance
Godrej Industries delivered strong financial results for FY26, characterized by broad-based growth across its diverse business portfolio. The consolidated Total Income for the year stood at ₹25,981 crore, representing a 19% increase over FY25. The company’s Net Profit also witnessed healthy growth, reaching ₹1,241 crore, up 26% from the previous year. For the fourth quarter (Q4) ending March 31, 2026, the company reported revenue of ₹8,274 crore and a quarterly net profit of ₹444 crore.
Segmental Highlights
The Estate and Property Development segment emerged as a key growth driver, contributing ₹8,504 crore to the total annual revenue and ₹2,862 crore in PBIT (Profit Before Interest and Tax). The Chemicals business maintained steady momentum, reporting ₹4,135 crore in revenue for the year, while Animal Nutrition and Finance and Investments segments reported annual revenues of ₹4,942 crore and ₹3,257 crore, respectively.
Strategic Corporate Developments
The company announced several strategic initiatives to bolster its future growth. The Board of Directors has approved raising funds through the issuance of Unsecured Non-Convertible Debentures (NCDs) for an amount up to ₹1,500 crore. Furthermore, the company has greenlit an additional investment of up to ₹1,000 crore in Godrej Investment Limited, its wholly-owned subsidiary, to further strengthen its financial services portfolio. These moves are subject to shareholder approval.
Leadership and Governance
In addition to financial results, the company announced the re-appointment of Mr. Vishal Sharma as Whole Time Director, designated as Executive Director & Chief Executive Officer (Chemicals). His tenure is set to run from April 1, 2027, to March 31, 2030, pending shareholder approval. Mr. Sharma brings 30 years of business experience and will continue to lead the chemicals business, focusing on global competitiveness and innovative chemistry.
Source: BSE
